Get a Quote

APIXABAN API | CAS 503612-47-3
CAS NO.: 503612-47-3
Chemical Formula: C25H25N5O4
Molecular Weight: 459.4970
DMF&GMP status: Please contact us for more details.
Description:
Apixaban helps to prevent platelets in your blood from sticking together and forming a blood clot.

Apixaban is used to lower the risk of stroke caused by a blood clot in people with a heart rhythm disorder called atrial fibrillation.

Apixaban is also used after hip or knee replacement surgery to prevent a type of blood clot called deep vein thrombosis (DVT), which can lead to blood clots in the lungs (pulmonary embolism).

Apixaban is also used to treat DVT or pulmonary embolism (PE), and to lower your risk of having a repeat DVT or PE.
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
APIXABANTABLET; ORAL2.5MGELIQUISBRISTOL MYERS SQUIBB
APIXABAN TABLET; ORAL 5MG ELIQUIS BRISTOL MYERS SQUIBB
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
641398022-Dec-19YYU - 1200
6413980 22-Dec-19 Y Y U - 1302
6413980 22-Dec-19 Y Y U - 1301
6413980 22-Dec-19 Y Y U - 1501
6967208 3-Feb-23 Y Y U - 1323
6967208 3-Feb-23 Y Y U - 1301
6967208 3-Feb-23 Y Y U - 1502
6967208 3-Feb-23 Y Y U - 1167
6967208 3-Feb-23 Y Y U - 1200
6967208 3-Feb-23 Y Y U - 1730
6967208 3-Feb-23 Y Y U - 1302
6967208 3-Feb-23 Y Y U - 1501
6967208 3-Feb-23 Y Y U - 1729
Exclusive Data
Exclusivity Code Exclusivity Expiration
NCE 28-Dec-17
I - 681 3-Mar-17
I - 690 21-Aug-17
I - 661 21-Aug-17
I - 691 21-Aug-17